• Sign In
  • Sign Out
  • My Account
Subscribe
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
  • Special reports
Clarivate
  • Data Snapshots
  • BioWorld
  • BioWorld MedTech
  • Infographics: Dynamic digital data analysis
  • Special reports
  • Infographics: Dynamic digital data analysis
  • Trump administration impacts
  • Biopharma M&A scorecard
  • BioWorld 2024 review
  • BioWorld MedTech 2024 review
  • BioWorld Science 2024 review
  • Women's health
  • China's GLP-1 landscape
  • PFA re-energizes afib market
  • China CAR T
  • Alzheimer's disease
  • Israel
  • Rise of obesity
  • Radiopharmaceuticals
  • Biosimilars
  • Aging
  • IVDs on the rise
  • Coronavirus
  • Artificial intelligence

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
Home » Topics » Briefs » Appointments and advancements

Appointments and advancements
Appointments and advancements RSS Feed RSS

Appointments and advancements for April 7, 2025

April 7, 2025
New hires and promotions in the biopharma industry, including: Alpenglow, Betterlife, Cosmo, Crescent, Cue Biopharma, Dark Blue, Exmoor, Formation Bio, Kalaris, Korro, Neurocrine, Novo Nordisk, Nxera, Oncozenge, Phathom, Tasman, Telix, Telo Genomics, Umecrine Cognition.
Read More

Appointments and advancements for April 4, 2025

April 4, 2025
New hires and promotions in the med-tech industry, including: Nalu Medical.
Read More

Appointments and advancements for April 4, 2025

April 4, 2025
New hires and promotions in the biopharma industry, including: Harmony, Verrica, Xaira.
Read More

Appointments and advancements for April 3, 2025

April 3, 2025
New hires and promotions in the med-tech industry, including: Fujifilm Sonosite, Life Spine, Perzeption.
Read More

Appointments and advancements for April 3, 2025

April 3, 2025
New hires and promotions in the biopharma industry, including: Aura, Endeavor, Inhibrx, Journey, Novadip, Rycarma, Sensorion.
Read More

Appointments and advancements for April 2, 2025

April 2, 2025
New hires and promotions in the med-tech industry, including: Append Medical, Catalyst Orthoscience, Corwave, Enovis, Fineheart.
Read More

Appointments and advancements for April 2, 2025

April 2, 2025
New hires and promotions in the biopharma industry, including: Adcendo, Aviceda, Cantargia, Climb, Codexis, ITM, Moma, Nuage, Pepgen, Realta, Synox, Transgene, Vectory, Ventyx.
Read More

Appointments and advancements for April 1, 2025

April 1, 2025
New hires and promotions in the med-tech industry, including: Adagio Medical, Cano Health, Neogenomics, Shimadzu Medical Systems.
Read More

Appointments and advancements for April 1, 2025

April 1, 2025
New hires and promotions in the biopharma industry, including: Atavistik, Novartis, Probiogen.
Read More

Appointments and advancements for March 31, 2025

March 31, 2025
New hires and promotions in the biopharma industry, including: Aeon, Defence, OSR, Sinovac, Tr1x, Xeris.
Read More
Previous 1 2 … 6 7 8 9 10 11 12 13 14 … 283 284 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for June 9, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for June 9, 2025.
  • The Nasdaq Stock Exchange headquarters in New York

    Omada, Caris arrivals continue med-tech IPO hot streak

    BioWorld MedTech
    Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, but it won’t be the most recent IPO...
  • Red blood cells in an artery with cholesterol

    In two phase IIIs, Merck’s PCSK9 inhibitor cuts cholesterol

    BioWorld
    In two phase III studies, Merck & Co. Inc.’s oral, once monthly proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor produced statistically significant...
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for June 3, 2025
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing

BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Israel
    • Rise of obesity
    • Radiopharmaceuticals
    • Biosimilars
    • Aging
    • IVDs on the rise
    • Coronavirus
    • Artificial intelligence

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe